These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 199988)

  • 1. [Relationship between the chemical structure and the biological activity of antibodies against the foot-and-mouth disease virus].
    Veleva EB
    Vet Med Nauki; 1977; 14(2):89-94. PubMed ID: 199988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of chemical modifiers on the antigen-binding capacity of antibodies].
    Veleva EB
    Vet Med Nauki; 1976; 13(10):47-54. PubMed ID: 193237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response in guinea pigs to foot-and-mouth disease virus. Study of the biological activities of IgG subclasses in hyperimmunized animal sera].
    Brunengo AM; Pérez AC; Massouh EJ
    Rev Argent Microbiol; 1980; 12(3):87-99. PubMed ID: 6292997
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Production of purified foot-and-mouth disease virus antigens and the specific sera against them].
    Tekerlekov P; Nikolova E; Vasileva L
    Vet Med Nauki; 1978; 15(6):21-8. PubMed ID: 85363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical studies of foot-and-mouth disease. VI. Differences in antigenic determinant site recognition by guinea pig 19S and 7S antibodies.
    Cowan KM
    J Immunol; 1970 Feb; 104(2):423-31. PubMed ID: 4312874
    [No Abstract]   [Full Text] [Related]  

  • 7. [Viral particle specific serums, used in complement fixation tests of foot-and-mouth disease virus].
    Roumiantzeff M; Fayet MT
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):833-51. PubMed ID: 4312138
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunochemical studies of foot-and-mouh disease. IX. Differences in neutralizing activities of guinea pig and bovine 19S and 7S antibodies.
    Wagner GG; Cown KM
    J Immunol; 1971 Mar; 106(3):656-60. PubMed ID: 4323129
    [No Abstract]   [Full Text] [Related]  

  • 9. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Foot-and-mouth disease in buffaloes (Bubalus bubalis, Linnaeus, 1758): search of antiantigen antibodies and isolation of the virus].
    Jerez JA; Pinto AA; Arruda NV; Koseki I; Abuhab TG; Rodrigues MA
    Arq Inst Biol (Sao Paulo); 1979; 46(3-4):111-5. PubMed ID: 233417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect complement fixation test with foot-and-mouth disease virus antigen concentrated by polyethylene glycol precipitation.
    Sakaki K; Suphavilai P; Kongthon S
    Natl Inst Anim Health Q (Tokyo); 1978; 18(1):8-17. PubMed ID: 206842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subtypes of the foot-and-mouth disease virus type O. Their antigenic and immunologic properties and mutual relationships].
    Wittmann G
    Zentralbl Bakteriol Orig; 1964 Sep; 194(1):1-25. PubMed ID: 4284199
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of methyl glyoxal on infectivity and antigenicity of foot-and-mouth disease virus.
    Ghizatullina NK
    Acta Virol; 1976 Oct; 20(5):380-6. PubMed ID: 11665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
    Garland AJ; Mowat GN; Fletton B
    Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response in bovine pharyngeal fluid following foot-and-mouth disease vaccination and, or, exposure to live virus.
    Francis MJ; Ouldridge EJ; Black L
    Res Vet Sci; 1983 Sep; 35(2):206-10. PubMed ID: 6314460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virus-neutralizing properties of rabbit anti-influenzal IgG with a lowered complement-binding and cytophilic activity].
    Tarkhanova IA; Rovnova ZI; Gnevkovskaia TV; Isaeva EI; Kul'berg AIa
    Biull Eksp Biol Med; 1977 Aug; 84(8):188-91. PubMed ID: 907822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivated-concentrated virus antigen for indirect complement fixation test of foot-and-mouth disease.
    Sakaki K; Suphavilai P; Chandarkeo T
    Natl Inst Anim Health Q (Tokyo); 1978; 18(3-4):128-34. PubMed ID: 216926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of foot-and-mouth disease antigen in bovine epithelial samples: comparison of sites of sample collection by an enzyme linked immunosorbent assay (ELISA) and complement fixation test.
    Oliver RE; Donaldson AI; Gibson CF; Roeder PL; Le Blanc Smith PM; Hamblin C
    Res Vet Sci; 1988 May; 44(3):315-9. PubMed ID: 2841733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
    Bauer K
    Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and expression of a single-chain antibody fragment specific for foot-and-mouth disease virus.
    Mason P; Berinstein A; Baxt B; Parsells R; Kang A; Rieder E
    Virology; 1996 Oct; 224(2):548-54. PubMed ID: 8874516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.